Clinical Trials
7 trialsNCT06075758 2026-05-06
A Study of Ribociclib in Combination With Hormonal Therapy in HR+/HER2- Advanced or Metastatic Breast Cancer
Novartis
Completed
NCT04943497 2026-04-01
PROSPERITY
Novartis
Completed
NCT07072013 2025-07-18
IRINA
Novartis
Completed
NCT03956654 2024-08-09
RibOB
Universitaire Ziekenhuizen KU Leuven
Completed
NCT06367335 2024-04-16
ETIC
University of Milano Bicocca
Completed
NCT05569187 2022-11-08
Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast Cancer
Novartis
Completed
NCT05153135 2021-12-21
Description of Treatment Patterns and Description and Comparison of Healthcare Resource Utilization and Costs of Women With Metastatic HR+/HER2- Breast Cancer Treated With CDK4/6 Inhibitors
Novartis
Completed